Different gene alterations in patients with non-small-cell lung cancer between the eastern and southern China
Geographical differences are conspicuous in lung cancer, and the distinct molecular features of lung tumor between Western patients and Asian patients have been demonstrated. However, the etiology of non-small-cell lung cancer (NSCLC) and the distribution of associated molecular aberrations in China...
Main Authors: | Chengdong Liu, Kangbao Li, Yi Sui, Hongmei Liu, Yunzhi Zhang, Yuan Lu, Wei Lu, Yongfeng Chen, Gehui Wang, Suqian Xu, Tianmin Xiang, Yongguang Cai, Kenan Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023073796 |
Similar Items
-
Investigating the genomic alteration improved the clinical outcome of aged patients with lung carcinoma
by: Sixian Chen, et al.
Published: (2022-01-01) -
Mutations and expressions of breast cancer 1/2 in lung cancer
by: Bokang Yan, et al.
Published: (2023-06-01) -
Efficacy of first‐line immune checkpoint inhibitors in patients with advanced NSCLC with KRAS, MET, FGFR, RET, BRAF, and HER2 alterations
by: Yuji Uehara, et al.
Published: (2022-06-01) -
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer
by: Nerea Otegui, et al.
Published: (2023-06-01) -
Gumarontinib in patients with non-small-cell lung cancer harbouring MET exon 14 skipping mutations: a multicentre, single-arm, open-label, phase 1b/2 trialResearch in context
by: Yongfeng Yu, et al.
Published: (2023-05-01)